Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool helps kids with cancer speak up about symptoms

NCT ID NCT04614662

Symptom relief Sponsor: The Hospital for Sick Children Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether having children with cancer report their symptoms three times a week using a web-based tool (SPARK) could improve their quality of life. The tool alerted healthcare providers and linked to care pathways for managing symptoms. A total of 445 children aged 8–18 from 20 hospitals took part. The goal was to reduce symptom burden and fatigue.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Symptom screening and care pathway tool (SPARK)
What this could lead to
If it works, this approach could help children with cancer feel better during treatment by catching and managing symptoms early.
What could go wrong
This is a completed trial, so results are available but may not show a big improvement. The tool only helps with symptoms, not the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

445 people

The number who actually took part.

Started

Aug 2021

Finished

Oct 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 8-18 years of age at enrollment * English or Spanish-speaking * Any newly diagnosed cancer * Have a plan for any chemotherapy, radiotherapy or surgery * Enroll within 28 days after treatment initiation Exclusion Criteria: * Cognitive disability (attending minimum second grade or equivalent) * Visual impairment (cannot see SPARK even with corrective lens)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pediatric cancer Quality of life

Contacts and locations

Locations

  • Children's Hospital

    New Orleans, Louisiana, 70118, United States

  • Children's Hospital Los Angeles

    Los Angeles, California, 90027-6062, United States

  • Connecticut Children's Medical Center

    Hartford, Connecticut, 06106, United States

  • Driscoll Children's Hospital

    Corpus Christi, Texas, 78411, United States

  • Kapi'olani Medical Center for Women & Children

    Honolulu, Hawaii, 96826, United States

  • Nemours Children's Health, Jacksonville

    Jacksonville, Florida, 32207, United States

  • Nemours Children's Hospital, Delaware

    Wilmington, Delaware, 19803, United States

  • Nemours Children's Hospital, Florida

    Orlando, Florida, 32827, United States

  • Phoenix Children's Hospital

    Phoenix, Arizona, 85016-7710, United States

  • Roswell Park Comprehensive Cancer Center

    Buffalo, New York, 14203, United States

  • The Hospital for Sick Children

    Toronto, Ontario, M5G 1X8, Canada

  • The Leland Stanford Junior University

    Redwood City, California, 94305-2004, United States

  • The Trustees of Columbia University in the City of New York

    New York, New York, 10032, United States

  • The University of Iowa

    Iowa City, Iowa, 52242, United States

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229-3901, United States

  • The University of Texas M. D. Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Unity Point Health - Blank Children's Hospital

    Des Moines, Iowa, 50309, United States

  • University of Colorado Denver

    Aurora, Colorado, 80045-2571, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203-1161, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23298-0568, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.